Literature DB >> 6869279

Abnormal cardiovascular regulation in the mitral valve prolapse syndrome.

F A Gaffney, B C Bastian, L B Lane, W F Taylor, J Horton, J E Schutte, R M Graham, W Pettinger, C G Blomqvist.   

Abstract

Studies of patients with mitral valve prolapse syndrome have suggested autonomic nervous system dysfunction, but a precise definition of mechanisms is lacking. We measured supine and standing heart rate, blood pressure, cardiac output, oxygen consumption, plasma catecholamines, and blood volume in 23 symptomatic women with both echocardiographic and phonographic signs of MVP and in 17 normal control subjects. An analysis of the results revealed 2 distinct subgroups of patients: those with normal heart rates but increased vasoconstriction (Group I, n = 10) and those with orthostatic tachycardia (Group II, n = 13). Group II patients had heart rates at rest supine of 97 +/- 3 compared with 79 +/- 2 in Group I patients and 78 +/- 8 in control subjects. Estimated total blood volumes were lowest in Group I patients, intermediate in Group II patients, and highest in control subjects (p less than 0.05). Other measurements at rest supine were similar in patients and controls. After standing for 5 minutes, patients had a higher mean plasma epinephrine value, diastolic blood pressure (81 +/- 2 versus 74 +/- 3 mm Hg, p less than 0.05), and peripheral resistance (1,878 +/- 114 versus 1,414 +/- 92, dynes s cm-5, p less than 0.01), wider arteriovenous oxygen difference (6.7 +/- 0.4 versus 5.3 +/- 0.5 vol%), and lower stroke volume index (26 +/- 2 versus 33 +/- 2 ml/m2, p less than 0.01) than did the control subjects. Cardiac output was normal in Group II patients but reduced in Group I patients, who demonstrated marked vasoconstriction. No patient had evidence of a "hyperkinetic" circulatory state. A cycle of decreased forward stroke volume, vasoconstriction, and blood volume contraction appears to be present in at least some symptomatic patients with MVP.

Entities:  

Mesh:

Year:  1983        PMID: 6869279     DOI: 10.1016/0002-9149(83)90130-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  P-wave dispersion and heart rate variability in children with mitral valve prolapse.

Authors:  Kadir Babaoglu; Gürkan Altun; Köksal Binnetoğlu
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

2.  Orthostatic hypotension in earthlings and space travelers.

Authors:  D Robertson; F A Gaffney; I Biaggioni
Journal:  West J Med       Date:  1992-12

3.  QT dispersion and ventricular arrhythmias in children with primary mitral valve prolapse.

Authors:  Ebru Yalın İmamoğlu; Ayşe Güler Eroğlu
Journal:  Turk Pediatri Ars       Date:  2016-09-01

4.  Haemodynamic and neurohormonal responsiveness to different stress tests in mitral valve prolapse.

Authors:  G Micieli; A Cavallini; G V Melzi d'Eril; C Tassorelli; F Barzizza; A P Verri; I Richichi; G Nappi
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

5.  Sir Thomas Lewis redivivus: from pebbles in a quiet pond to autonomic storms.

Authors:  T N James
Journal:  Br Heart J       Date:  1984-07

6.  Floppy Mitral Valve, Mitral Valve Prolapse, and Mitral Valvular Regurgitation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-02

7.  A relationship between mitral valve prolapse and subtypes of supraventricular tachycardia.

Authors:  Alim Erdem; Osman Can Yontar; Serkan Öztürk; Suzi Selim Ayhan; Mehmet Fatih Özlü; Fatma Hizal Erdem; Mehmet Yazici
Journal:  J Interv Card Electrophysiol       Date:  2012-08-14       Impact factor: 1.900

8.  Orthostatic hypotension, catecholamines, and alpha-adrenergic receptors in mitral valve prolapse.

Authors:  I J Schatz; S Ramanathan; R Villagomez; C MacLean
Journal:  West J Med       Date:  1990-01

Review 9.  The mitral valve prolapse epidemic: fact or fiction.

Authors:  R P Lewis; C F Wooley; A J Kolibash; H Boudoulas
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

10.  Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade.

Authors:  G S Butrous; M B Maltz; J O'Keefe; S O Banim; A J Camm
Journal:  Postgrad Med J       Date:  1986-04       Impact factor: 2.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.